多参数超声评估慢性肝病:私立门诊连续病例研究
本研究在私立门诊连续纳入110例皮肤至肝脏距离增大的患者,采用多参数超声(肝硬度、衰减成像、剪切波色散斜率)评估慢性肝病,平均检查时间129.7±62.1秒,4.5%的LS值和4.5%的脂肪定量测量不可靠,20.9%患者提示代偿期进展性慢性肝病。
要点
- 皮肤至肝脏距离增大患者中多参数超声仍可在约2分钟内完成,但需关注测量可靠性。
- 肝硬度IQR/M为12.3±5.5% m/s,4.5%的LS值不可靠。
- 衰减成像IQR/M为14.7±9.2%,4.5%的脂肪定量不可靠。
关键影像表现/征象
- 肝硬度平均IQR/M为12.3±5.5% m/s,4.5%的LS值不可靠。
- 衰减成像均值0.60±0.15 dB/cm/MHz(范围0.35-0.98 cm/dB/MHz),IQR/M为14.7±9.2%,4.5%患者脂肪定量不可靠。
- 剪切波色散斜率均值12.74±4.05 (m/s)/kHz(范围7.7-27.5 (m/s)/kHz),IQR/M为38.7±20.2%(范围3-131%)。
- 20.9%患者测值提示代偿期进展性慢性肝病(cACLD)。
诊断标准与关键数值
- 肝硬度可靠性以IQR/M表示,均值12.3±5.5% m/s,4.5%的LS值不可靠。
- 脂肪定量可靠性以IQR/M表示,均值14.7±9.2%,4.5%患者测量不可靠。
- 剪切波色散斜率IQR/M均值38.7±20.2%,范围3-131%。
- 代偿期进展性慢性肝病(cACLD)的判定未在原文中给出具体阈值。
临床应用与阅片要点
- 对皮肤至肝脏距离增大的困难患者,多参数超声仍可在约2分钟内完成,但需关注IQR/M评估可靠性。
- 肝硬度和脂肪定量不可靠比例约4.5%,阅片时应结合IQR/M判断测量质量。
- 剪切波色散斜率IQR/M较高(38.7±20.2%),重复性较差,解读需谨慎。
局限性
- 单中心私立门诊回顾性研究,样本量110例,结论外推需谨慎。
- 未报告诊断敏感度、特异度、AUC及cACLD具体阈值。
- 皮肤至肝脏距离增大可能影响测量成功率,但原文未分析失败原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To assess chronic liver disease (CLD) using multiparametric US in a private practice setting in a cohort of patients with increased skin-to-liver distance.
METHODS: 110 consecutive patients with increased skin-to-liver distance scheduled for US assessment of CLD were reviewed for study completion time, liver stiffness values (LS), attenuation imaging, and shear wave dispersion slope. The ROI was placed 2 cm below the liver capsule. The study included patients with NAFLD/NASH (68), hepatitis C (30), prior Fontan surgery (1), elevated liver function tests (5), alcohol abuse (3), hepatitis B (2), and primary biliary cirrhosis (1). IQR/M values were obtained. Comparison of less experienced sonographers (LES) and more experienced sonographers (MES) were evaluated through Student's t test for independent data. Pearson coefficient r of correlation among quantitative variables was calculated.
RESULTS: The mean time to perform the exam was 129.7 ± 62.1 s. There was a statistically significant difference between LES and MES. The mean IQR/M for LS was 12.3 ± 5.5% m/s. Overall, in a cohort of difficult patients, 4.5% of LS values were not reliable. Fat quantification using attenuation imaging had a mean value of 0.60 ± 0.15 dB/cm/MHz (range 0.35-0.98 cm/dB/MHz) with an IQR/M of 14.7 ± 9.2%. Less reliable measurements of steatosis were obtained in 4.5% of patients. The mean shear wave dispersion slope was 12.74 ± 4.05 (m/s)/kHz (range 7.7-27.5 (m/s)/kHz) with an IQR/M of 38.7 ± 20.2% (range 3-131%). 20.9% of patients had values suggestive of compensated advanced chronic liver disease (cACLD).
CONCLUSION: Multiparametric US can provide assessment of CLD in less than 3 min in most patients and identify patients at risk for cACLD.
引用
- Aitharaju V, De Silvestri A, Barr RG, et al. Assessment of chronic liver disease by multiparametric ultrasound: results from a private practice outpatient facility. Abdom Radiol (NY). 2021. PMID: 34304291. doi:10.1007/s00261-021-03225-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。